Background: Case reports have hypothesised that proteinuria, sometimes with glomerulopathy or nephrotic syndromes, might be associated with loiasis. To our knowledge, no study has been done to assess this association. We aimed to investigate the association between Loa loa microfilariae burden and proteinuria.

Methods: We did a cross-sectional study between May 16, 2022, and June 11, 2022, to assess the relationship between Loa loa microfilaraemia densities and proteinuria in a rural area of the Republic of Congo. We included all consenting adults living in the target area at study commencement who had L loa microfilarial densities greater than 500 microfilariae per mL during previous screening for a clinical trial in 2019. This study is part of the MorLo project, and used the project's study population of individuals aged 18 years or older who were living near Sibiti. For each microfilaraemic individual, two individuals without L loa microfilarial densities matched on age, sex, and place of residence were included. The association between proteinuria (assessed by dipstick) and L loa microfilarial densities, age, and sex was assessed using an unconstrained ordinal regression model since the parallel-lines assumption was violated for microfilarial densities.

Findings: 991 participants were included, of whom 342 (35%) were L loa microfilaraemic. The prevalence of microfilaraemia was 38% (122 of 325) among individuals with trace proteinuria (<300 mg/24 h), 51% (45 of 89) among individuals with light proteinuria (300 mg to 1 g/24 h), and 71% (15 of 21) among individuals with high proteinuria (>1 g/24 h). Individuals with high proteinuria had significantly higher L loa microfilarial densities (p<0·0001): mean microfilariae per mL were 1595 (SD 4960) among individuals with no proteinuria, 2691 (7982) for those with trace proteinuria, 3833 (9878) for those with light proteinuria, and 13 541 (20 118) for those with high proteinuria. Individuals with 5000-14 999 microfilariae per mL and individuals with 15 000 microfilariae per mL or greater were, respectively, 5·39 and 20·49 times more likely to have a high proteinuria than individuals with no microfilaraemia.

Interpretation: The risk of proteinuria increases with L loa microfilaraemia. Further studies are needed to identify renal disorders (eg, tubulopathies, glomerulopathies, or nephrotic syndromes) responsible for loiasis-related proteinuria.

Funding: European Research Council, MorLo project.

Translation: For the French translation of the abstract see Supplementary Materials section.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469262PMC
http://dx.doi.org/10.1016/S2666-5247(23)00142-8DOI Listing

Publication Analysis

Top Keywords

loa microfilarial
20
microfilarial densities
16
loa loa
12
loa
11
rural area
8
area republic
8
republic congo
8
morlo project
8
cross-sectional study
8
age sex
8

Similar Publications

We assessed the impact of loiasis and its treatment with ivermectin on hemostasis and inflammation in 38 adults in Cameroon. Participants were divided into four balanced groups based on their Loa loa microfilarial densities. At baseline, eosinophils and platelets increased with microfilarial densities (p<0.

View Article and Find Full Text PDF

Background: The standard method to diagnose Loa loa infection and quantify microfilarial density (MFD) is the microscopic examination of calibrated thick blood smears (TBSs). In 1950, it was noticed that successive L. loa MFD samples from a single capillary puncture could exhibit up to 20% variation.

View Article and Find Full Text PDF

Ocular loaiasis in France: the first case report from Brittany.

J Ophthalmic Inflamm Infect

November 2024

Univ Brest, CHU Brest, Brest, F-29200, France.

We report the case of a 21-year-old Cameroonian woman residing in France for one year, who presented to our department with left eye discomfort and itching. Examination revealed a mobile translucent cord beneath the nasal-inferior conjunctiva, prompting suspicion of loaiasis. Anesthesia was administered for extraction, revealing a 31 mm male Loa loa.

View Article and Find Full Text PDF

A novel antigen biomarker for detection of high-level of Loa loa microfilaremia.

PLoS Negl Trop Dis

September 2024

Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, United States of America.

Article Synopsis
  • Loiasis is a disease caused by the Loa loa nematode, which can lead to serious side effects in people with high levels of the parasite after treatment with ivermectin, complicating elimination efforts for lymphatic filariasis and onchocerciasis in Central Africa.
  • Researchers developed a new antigen capture ELISA test to detect a specific protein, Ll-Bhp-1, in loiasis patients, finding it present in 63.8% of samples and strongly correlated with high parasite counts.
  • This Ll-Bhp-1 antigen test is both specific to loiasis and effective at identifying patients at high risk for adverse reactions to ivermectin, thereby aiding in disease mapping and elimination programs in the affected regions.
View Article and Find Full Text PDF

Background: In 2018, the US Food and Drug Administration approved the macrocylic lactone moxidectin (MOX) at 8 mg dosage for onchocerciasis treatment in individuals aged ≥12 years. Severe adverse reactions have occurred after ivermectin (IVM), also a macrocyclic lactone, in individuals with high microfilarial density (MFD). This study compared the safety and efficacy of a 2 mg MOX dose and the standard 150 µg/kg IVM dose in individuals with low MFD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!